Thrombin-induced platelet inhibition by 2',4'-dihydroxychalcone and 2',4'-dihydroxydihydrochalcone is mediated by inhibition of ROS production and Thromboxane synthase a activity: structure-activity relationship of polyphenol secondary metabolites from Empetrum nigrum.
The researchers tested compounds for inhibiting platelet activation by targeting ROS, TxS, and cyclic nucleotide pathways. Compounds and showed significant inhibition, key for potential use with P2Y12 inhibitors. Identifying new ways to control platelet activation is important for preventing clot-related diseases.
- Fock E et al (2024).
- Nat Prod Res.
- PubMed:
- 38567701